Brief: Entrada Therapeutics Says Pricing Of Its Upsized IPO Of 9,075,000 Shares Of Common Stock At $20 Per Share
Oct 28 (Reuters) - Entrada Therapeutics Inc TRDA.O :
* PRICING OF ITS UPSIZED INITIAL PUBLIC OFFERING OF
9,075,000
SHARES OF COMMON STOCK, AT $20.00 PER SHARE
Source text for Eikon: ID:nGNX2q4pJ1
Further company coverage: TRDA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Entrada Therapeutics
See all newsBrief: Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Entrada Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Entrada Therapeutics Q2 Collaboration Revenue USD 898 Thousand
Entrada Therapeutics Q2 net loss narrows on lower costs
Entrada Therapeutics Inc expected to post a loss of $1.05 a share - Earnings Preview